Log In
BCIQ
Print this Print this
 

CB301

  Manage Alerts
Collapse Summary General Information
Company Cantabio Pharmaceuticals Inc.
DescriptionSmall molecule targeting beta amyloid
Molecular Target Beta amyloid
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today